Atlas Trials

Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients

Clinical trial NCT05346783 · UNKNOWN

Trial details

NCT number
NCT05346783
Sponsor
Taejoon Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Dry Eye Syndromes
Start date
2021-10-14
Primary completion
2022-12-01
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.